BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: L'Amoreaux WJ, Marsillo A, El Idrissi A. Pharmacological characterization of GABAA receptors in taurine-fed mice. J Biomed Sci 2010;17 Suppl 1:S14. [PMID: 20804588 DOI: 10.1186/1423-0127-17-S1-S14] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mekawy N, Bendaoud M, Yachou Y, El Idrissi A. Hyperreflexia and enhanced ripple oscillations in the taurine-deficient mice. Amino Acids 2021;53:701-12. [PMID: 33877450 DOI: 10.1007/s00726-021-02977-x] [Reference Citation Analysis]
2 Chung MC, Malatesta P, Bosquesi PL, Yamasaki PR, Santos JL, Vizioli EO. Advances in drug design based on the amino Acid approach: taurine analogues for the treatment of CNS diseases. Pharmaceuticals (Basel) 2012;5:1128-46. [PMID: 24281261 DOI: 10.3390/ph5101128] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
3 Francisco EDS, Guedes RCA. Sub-Convulsing Dose Administration of Pilocarpine Reduces Glycemia, Increases Anxiety-Like Behavior and Decelerates Cortical Spreading Depression in Rats Suckled on Various Litter Sizes. Front Neurosci 2018;12:897. [PMID: 30559645 DOI: 10.3389/fnins.2018.00897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Gonzalez-Vazquez A, Aguilar-Peralta AK, Tomas-Sanchez C, Blanco-Alvarez VM, Martinez-Fong D, Gonzalez-Barrios JA, Treviño S, Millán-Perez Peña L, Alatriste V, Soto-Rodriguez G, Brambila E, Leon-Chavez BA. Taurine Increases Zinc Preconditioning-Induced Prevention of Nitrosative Stress, Metabolic Alterations, and Motor Deficits in Young Rats following Intrauterine Ischemia. Oxid Med Cell Longev 2021;2021:6696538. [PMID: 34040692 DOI: 10.1155/2021/6696538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Paluszkiewicz SM, Martin BS, Huntsman MM. Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev Neurosci 2011;33:349-64. [PMID: 21934270 DOI: 10.1159/000329420] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 9.5] [Reference Citation Analysis]
6 Jakaria M, Azam S, Haque ME, Jo SH, Uddin MS, Kim IS, Choi DK. Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biol 2019;24:101223. [PMID: 31141786 DOI: 10.1016/j.redox.2019.101223] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
7 Schaffer S, Kim HW. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul) 2018;26:225-41. [PMID: 29631391 DOI: 10.4062/biomolther.2017.251] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 19.8] [Reference Citation Analysis]
8 Huang KH, Chang CC, Ho JD, Lu RH, Tsai LH. Role of taurine on acid secretion in the rat stomach. J Biomed Sci 2011;18:11. [PMID: 21294907 DOI: 10.1186/1423-0127-18-11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]